Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2021)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Interest & Investment Income came in at $23311.0 in Q2 2021, up 84.29% year-on-year from $12649.0 in Q2 2020, and up 181.04% quarter-over-quarter from -$28765.0 in Q1 2021.
Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2021) Analysis & Trends
Corbus Pharmaceuticals Holdings' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $23311.0 for Q2 2021.
- On a quarterly basis, Interest & Investment Income rose 84.29% year-over-year to $23311.0 in Q2 2021; TTM through Jun 2021 was $109188.0, a 87.84% decrease from a year earlier, with the FY2019 full-year figure at $1.2 million, up 24.92% from the prior year.
- Interest & Investment Income improved to $23311.0 in Q2 2021 per CRBP's latest filing, from -$28765.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $448717.0 in Q2 2019 and bottomed at -$28765.0 in Q1 2021.
- The 3-year median for Interest & Investment Income is $62652.0 (2020), against an average of $148750.0.
- Biggest YoY gain for Interest & Investment Income was 84.29% in 2021; the steepest drop was 128.2% in 2021.
- Year by year, Interest & Investment Income stood at $448717.0 in 2019, then sank by 97.18% to $12649.0 in 2020, then soared by 84.29% to $23311.0 in 2021.
- Per Business Quant, the three latest CRBP Interest & Investment Income figures stand at $23311.0 (Q2 2021), -$28765.0 (Q1 2021), and $12649.0 (Q2 2020).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 23,311.00 |
| Mar 31, 2021 | -28,765.00 |
| Jun 30, 2020 | 12,649.00 |
| Mar 31, 2020 | 101,993.00 |
| Jun 30, 2019 | 448,717.00 |
| Mar 31, 2019 | 334,595.00 |
| Mar 31, 2016 | 1,070.00 |
| Dec 31, 2015 | 1,272.00 |
| Sep 30, 2015 | 1,037.00 |
| Jun 30, 2015 | 548.00 |
| Mar 31, 2015 | 560.00 |
| Dec 31, 2014 | 690.00 |
| Sep 30, 2014 | 802.00 |
| Jun 30, 2014 | 578.00 |
| Mar 31, 2014 | 45.00 |
| Dec 31, 2013 | 59.00 |
| Sep 30, 2013 | 128.00 |